Brahm Hillel Segal MD
Healthcare Associated Infections, Transplant/Immunocompromised States
Chair, Dept. of Internal Medicine, Moffitt Cancer Center
Join to View Full Profile
12902 Usf Magnolia DrTampa, FL 33612
Phone+1 813-745-7365
Fax+1 813-449-8618
Dr. Segal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brahm Segal is an infectious disease specialist based in Tampa, FL, with expertise in healthcare-associated infections and transplant/immunocompromised states. He completed his residency in internal medicine at Tufts Medical Center and a fellowship in infectious disease at the National Institutes of Health Clinical Center. Dr. Segal serves as Chair at Moffitt Cancer Center since 2025, following his role as Chairman at Roswell Park Comprehensive Cancer Center from 2018 to 2025. He has contributed to numerous publications, including research on infections in cancer patients and the impact of glucocorticoids on cancer treatments. His involvement in clinical trials includes studies on COVID-19 treatment in cancer patients. Dr. Segal received several CMS Meaningful Use Stage 1 Certifications related to healthcare technology in 2013-2014.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1995 - 1997
Tufts Medical CenterResidency, Internal Medicine, 1992 - 1995
Albert Einstein College of MedicineClass of 1992
Certifications & Licensure
FL State Medical License 2024 - 2027
NY State Medical License 1999 - 2026
MD State Medical License 1996 - 1999
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2013-2014
- CMS Meaningful Use Stage 1 Certification Sunrise Patient Portal and Sunrise Acute Care EHR, Allscripts, 2013-2014
- CMS Meaningful Use Stage 1 Certification Sunrise Acute Care Module Set, Allscripts, 2013-2014
Clinical Trials
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
- Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients Start of enrollment: 2020 Nov 17
Publications & Presentations
PubMed
- Incidence Rates of Candida Bloodstream Infections in Patients With Malignancies in a Comprehensive Cancer Centre.Mohammad El-Atoum, George L Chen, John P Bonnewell, Brahm H Segal, Nikolaos G Almyroudis
Mycoses. 2025-12-01 - 1 citationsNC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression.Thejaswini Giridharan, Sora Suzuki, Anm Nazmul H Khan, Qian Liu, Kristopher Attwood
Journal of Immunology. 2025-09-01 - 2 citationsImpact of Glucocorticoids on Immune Checkpoint Inhibitor Efficacy and Circulating Biomarkers in Non-Small Cell Lung Cancer Patients.Lauren Polyakov, Angelina Lim, Alexandra Meyer, Aubree Mades, Joshua Ni
Cancer Research Communications. 2025-07-01
Press Mentions
Castle Connolly Names 38 Roswell Park Physicians to ‘Top Doctors’ ListFebruary 2nd, 2023- Roswell Park Oncology Experts Named to Castle Connolly ‘Top Doctors’ ListAugust 4th, 2022
- NextCure Provides Business Update and Reports Second Quarter 2022 Financial ResultsAugust 4th, 2022
Grant Support
- Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancerROSWELL PARK CANCER INSTITUTE CORP2022–2027
- Role Of Nadph Oxidase In Regulating InflammationNational Institute Of Allergy And Infectious Diseases2009–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
